Retinitis pigmentosa is blinding eye disease that affects approximately 150,000 individuals in the US and 1.5 million people around the world. It is caused by the destruction of light-sensing cells… ...

The mission of California Institute for Regenerative Medicine (CIRM) is to accelerate stem cell treatments to patients with unmet medical needs. With our Clinical Stage Programs, we intend to speed up ...

To listen or to remotely participate in oral public comment: Dial (669) 900-6833, or dial the toll free (833) 548-0282 Members of the public attending the meeting at a teleconference location will be ...

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.

South San Francisco, Calif., January 30, 2026 – The California Institute for Regenerative Medicine (CIRM) has approved a new funding program to accelerate therapies for rare diseases, which sets aside ...

South San Francisco, CA, December 11, 2025 – The California Institute for Regenerative Medicine (CIRM) governing board today approved funding of over $160 million for 16 new research awards to develop ...

At the California Institute for Regenerative Medicine (CIRM), we are committed to the continued funding of groundbreaking research in regenerative medicine. To reflect this commitment, we are ...

South San Francisco, Calif., October 30, 2025 – The California Institute for Regenerative Medicine (CIRM) has approved awarding $27 million through three grants across the state to create a network of ...

这项工作找到了促进肌肉祖细胞更好地形成骨骼肌的新方法，这可用于增强患有获得性或遗传性肌病的人的肌肉愈合。 科学摘要： 细胞膜由多种脂质组成，例如磷脂酰丝氨酸（PS）、磷脂酰胆碱 ...

The mission of the California Institute for Regenerative Medicine (CIRM) is to accelerate world class science to deliver transformative regenerative medicine treatments in an equitable manner to a ...

由人胚胎干细胞（hESC）产生的心肌细胞具有多种潜在的应用，包括用于心肌修复的细胞移植。在这里，我们提供基于从 H7 和 H9 hESC 生成心肌细胞的工作的协议。这些 hESC 系特异性方案可重复地 ...

纤维化是一种组织增厚和疤痕化的疾病，是间质性肺病 (ILD) 等肺部疾病的一个重要问题。 在健康的肺中，不同类型的细胞之间存在着微妙的平衡——尤其是肺泡成纤维细胞和上皮细胞。 这种 ...